A Georgia State University researcher is documenting the experiences of long-haulers, people who remain sick long after being diagnosed with COVID-19.
Under normal circumstances, Georgia State nursing students go to a hospital or other medical facility for practical experience, called clinical. But because of the COVID-19 pandemic, students instead sign on to clinical experience via video conferencing.
The technology is anticipated to provide several benefits, including fast turnaround time and greatly decreased false negative outcomes.
Dr. Christopher Basler, professor and director of the Center for Microbial Pathogenesis in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.94 million federal grant to study unique features of Ebola and Marburg viruses that control how the virus family expresses its genes and escapes immune responses.
A new antiviral drug that is effective against a broad range of human pathogens in the paramyxovirus family, such as the human parainfluenzaviruses and measles virus, has been discovered by researchers in the Institute for Biomedical Sciences at Georgia State University.
The program is designed to educate incoming freshmen and others on how to prevent and intervene against sexual assault.
Dr. Richard Plemper, Distinguished University Professor in the Institute for Biomedical Sciences, has been awarded a five-year, $3.65 million grant from the National Institutes of Health to develop antiviral therapeutics for the treatment of respiratory syncytial virus (RSV) infections.
Georgia State University and Augusta University will provide grants totaling nearly $200,000 to support four research collaborations among faculty from both institutions.
Part of a research team that uses mathematical models to study how the environment affects transmission of SARS-CoV-2, the novel coronavirus, Gerardo Chowell is helping to produce daily forecasts of the virus’ trajectory.
Perimeter College student Tiffany Watts-Ferguson spends her workdays calling those who have taken a COVID-19 test to tell them the results.
